Inge Jeding-Jansen

Inge Jeding-Jansen possesses extensive expertise in pharmacovigilance and global safety, currently serving as Head of Global Safety & Pharmacovigilance - Senior Director at ALK since May 2022. Previously, Jeding-Jansen held prominent roles at LEO Pharma as Head of Global Safety Surveillance Marketed Products, and at A-consult A/S as Head of Pharmacovigilance & Product Safety. Other significant positions include leading Global Patient Safety at Allergan, serving as Vice Chairman for the Safety & Pharmacovigilance Group at Medicines for Europe, and holding director-level roles at Actavis and Lundbeck. Jeding-Jansen's educational background includes a Postgraduate Certificate in Pharmacovigilance and degrees in Human Biology and Pharmacy from Københavns Universitet and the University of Hertfordshire.